waveLINE-006: A phase 2 study of the safety and efficacy of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B-cell malignancies.

Zinzani P. L., Mayer J., Benjamini O., Berkovits A., Glimelius I., Stevens D. A., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.41, sa.16, 2023 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 41 Sayı: 16
  • Basım Tarihi: 2023
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
  • Ankara Üniversitesi Adresli: Evet